Free Trial
NASDAQ:BLFS

BioLife Solutions Q3 2026 Earnings Date & Estimates

BioLife Solutions logo
$38.61 0.00 (0.00%)
As of 10/9/2026

BioLife Solutions is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET

What Analysts Expect from BioLife Solutions in Q3 2026

BioLife Solutions is expected to post earnings of $0.05 per share on revenue of $29.13 million. BioLife Solutions last reported on August 6, 2026, posting $0.91 per share and beating the $0.0313 consensus estimate. BioLife Solutions has beaten the consensus EPS estimate in 7 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.05
Expected Revenue
$29.13 million

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.91 (Beat by +$0.8788)
Last Quarter Revenue
$28.47 million
EPS Beat Rate
7 of last 8 quarters

BioLife Solutions Q3 2026 Earnings FAQ

BioLife Solutions (NASDAQ:BLFS) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes.

BioLife Solutions' Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect BioLife Solutions to post earnings of $0.05 per share for Q3 2026.

The consensus revenue estimate for BioLife Solutions is $29.13 million for Q3 2026.

BioLife Solutions Earnings Headlines

BioLife Solutions, Inc.(NasdaqCM:BLFS) dropped from S&P 1000
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Repligen Closes BioLife Solutions Acquisition
See More BioLife Solutions Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioLife Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioLife Solutions and other key companies, straight to your email.

About BioLife Solutions

BioLife Solutions (NASDAQ:BLFS) is a life sciences technology company that develops and supplies products used to preserve, store, process and transport cells and tissues. Its solutions support the development and commercialization of cell and gene therapies, as well as other biological materials that require controlled temperature and handling conditions.

The company’s product portfolio includes biopreservation media such as CryoStor and HypoThermosol, cryogenic storage bags and containers, controlled-rate freezing systems, automated thawing equipment and related laboratory tools. BioLife also offers software and data-management solutions designed to help customers monitor and manage bioproduction and cold-chain workflows.

BioLife Solutions serves biopharmaceutical and biotechnology companies, contract development and manufacturing organizations, academic institutions and research laboratories. Its operations and customer base extend across the United States and international markets. The company is headquartered in Bothell, Washington, and has expanded its offerings through acquisitions and the development of complementary technologies for cell and gene therapy manufacturing.

View BioLife Solutions Profile